ABSTRACT-The inhibitory effect of 1,9-dideoxyforskolin (DFK) on the contraction of rat aorta was compared with that of forskolin. DFK inhibited the contraction induced by high K+ more strongly than that induced by norepinephrine, whereas forskolin more strongly inhibited the norepinephrine-induced contraction. The inhibitory effect of DFK on high K+-induced contraction was antagonized by an in crease in extracellular Ca 2+ concentration. DFK inhibited the increase in cytosolic Ca 2+ level and con traction in parallel whereas forskolin inhibited the contraction more strongly than the cytosolic Ca 2+ level. These results suggest that DFK, but not forskolin, inhibits vascular smooth muscle contraction by a Ca 2+ channel blocker-like action.
Forskolin is a direct and potent activator of adenylate cyclase (1) which relaxes vascular smooth muscle by de creasing the cytosolic Ca 2+ level ([Ca 2 +]j) and Ca 2+ sensitivity of contractile elements (2) . Recently, how ever, it has been shown that forskolin has effects that are not attributable to the production of cyclic AMP (3) . A naturally occurring analogue of forskolin, 1,9 dideoxyforskolin (DFK), does not activate adenylate cyclase (4) and still has various pharmacological effects (for a review, see ref. 5) . From their structural similar ity, it is expected that DFK and forskolin might share a pharmacological effect that is not related to the activa tion of adenylate cyclase. However, effect of DFK on vascular smooth muscle contraction is yet unclear. To examine the above possibility, we compared the effects of DFK and forskolin on contraction and [Ca 2+]i in vascular smooth muscle of rat aorta. Our results suggest that DFK and forskolin inhibit vascular smooth muscle contraction by different mechanisms.
The thoracic aorta was isolated from male Wistar rat (200 250 g) and cut into transverse strips (2 3 mm wide and 5 6 mm long [Ca 2+]i was measured with a fluorescent Ca 2+ indi cator, fura-2, as reported previously (2, 6) . Muscle strips were treated with the acetoxymethyl ester of fura-2 (5 ,u M) for 3-4 hr at room temperature. Fura-2-Ca 2+ signals and muscle tension were measured simultane ously with a fluorimeter (CAF-100, JASCO). The mus cle strip was excited alternately by 340 nm and 380 nm light and the ratio (R340/380) of the 500 nm fluores cence due to excitation at 340 nm (F340) to that at 380 nm (F380) was calculated from the values of suc cessive illumination periods. Since it was difficult to evaluate the dissociation constant of fura-2 for Ca 2+ in the cytoplasm (7), R340/380 was used as an indicator of [Ca 2+]i (2, 6) . In a preliminary experiment, it was found that DFK slightly decreased both F340 and F380 in parallel without changing R340/380. This result indi cates that although DFK interferes with the fura-2 fluorescence, R340/380 can be used as an indicator of relative [Ca 2+1i. It was also confirmed that the effect of DFK was not modified by the fura-2-loading. . DFK also inhibited the norepinephrine (NE)-induced contraction. However, the inhibitory effect of DFK on the NE-induced contraction (IC50 > 4.5 -log M, n = 4) was much weaker than that on the high K+-induced contraction. In contrast, forskolin in hibited the NE-induced contraction more strongly than the high K+-induced contraction (see Fig. 3 and refs. 2 and 8). These results suggest that DFK and forskolin have different mechanisms of action. Since Ca 2+ chan nel blockers inhibit the high K+-induced contraction more strongly than the NE-induced contraction (for a review, see ref. 9), we determined if DFK has a Ca 2+ channel blocker-like action.
As shown in Fig. 1 , the inhibitory effect of DFK on high K+-induced contraction was antagonized by in creasing the extracellular Ca 2+ concentration from 1.5 mM to 6.0 mM (IC50 = 5.09 ± 0.06 -log M, n = 4, P < 0.01). However, a Ca 2+ channel agonist, 0.3,uM Bay k8644, did not modify the effect of DFK (IC5o = 5.21 ± 0.08 -log M, n = 4). Since Bay k8644 has been shown to antagonize the effects of dihydropyridines, verapamil and diltiazem but not those of diphenyl alkyl amines (10), DFK might have an effect similar to the Bay k8644-insensitive group of Ca 2+ channel blockers. This possibility was further confirmed by measuring
As shown in Fig. 2 , high K+ increased both [Ca 2+]i and muscle tension. DFK (10 and 30 ,u M) inhibited the high K+-stimulated [Ca 2+]i and muscle tension in a concentration-dependent manner. The effects of DFK and forskolin on [Ca 2+]i and muscle tension are summarized in Fig. 3 . The data demonstrate that DFK inhibited [Ca 2+]i and muscle tension in parallel. These effects of DFK were quite similar to those obtained with verapamil (6, 11) . In contrast, 1,uM forskolin in hibited the contractions more strongly than [Ca 2+]i, as reported previously (2, 7). These results suggest that 1 ,u M forskolin, but not 10 and 30 ,u M DFK, decreases the Ca2+-sensitivity of the contractile elements in smooth muscle. Lower concentration of forskolin (0.1 ,u M) inhibited the NE-induced changes with little effect on the high K+-induced changes. This effect may be due to inhibition of phosphatidylinositol turnover (12) .
Comparison of the results in Figs. 1 and 3 indicates that the concentration-inhibition curve for DFK was shifted to the right by approximately 0.5 log unit in the fura-2-loaded aorta. Since we confirmed that fura-2 loading did not change the effect of DFK, it is possible that the effect of DFK did not reach an equilibrium in the fura-2 experiments; since fura-2 gradually leaks out of the cell, it was not possible to observe the effect of DFK for longer than 20 30 min.
All of these results suggest that DFK inhibits vascular smooth muscle contraction by a Ca 2+ channel blocker like action. In pheochromocytoma PC12 cells, it has been demonstrated that DFK, but not forskolin, has nonspecific inhibitory effects on a variety of ion chan nels (13) . DFK might have similar effects in rat aorta.
In cardiac cells, in contrast, it has been shown that fors kolin but not DFK inhibits the L-type Ca 2+ current, which is recovered by Bay k8644 (5) . This discrepancy may be due to a tissue difference in L-type Ca 2+ chan nels.
In vascular smooth muscle, it has been shown that although forskolin also decreases [Ca 2+]i (2), this is not due to direct inhibition of L-type Ca 2+ channels (12, 14) , but due to the indirect effect by either inhibition of phosphatidylinositol hydolysis (12) or activation of K+ channels (7) . In addition, forskolin has an effect to de crease the Ca t+-sensitivity of the contractile elements (2, 7). These effects may be due to the increase in cAMP content because dibutyryl cAMP has effects similar to those of forskolin (12, 15) .
In summary, the results showing that 1) DFK inhib ited the high K+-induced contraction more strongly than the NE-induced contraction, 2) DFK inhibited high K+-stimulated [Ca Z+]i and muscle tension in parallel, and 3) the inhibitory effect of DFK was antagonized by the increase in external Ca 2+ concentrations suggest that the inhibitory effect of DFK is attributable to a Ca 2+ channel blocker-like action. 
